輸入代號或公司名稱後按 Enter
1788

杏昌

-0.50 (-0.39%)最後更新 2026-09-16
台灣 · 上櫃 · 生技醫療業
128.0018成交張數14.60本益比1.94股價淨值比5.45%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入20254,278年增 +5.0%
毛利率202526.7%最新一期
營業利益率20259.8%最新一期
每股盈餘20258.28年增 +2.5%
會計項目走勢20212022202320242025
營業收入合計100.0%100.0%100.0%100.0%100.0%
營業成本合計73.7%77.7%73.9%73.7%73.3%
營業毛利(毛損)26.3%22.3%26.1%26.3%26.7%
營業毛利(毛損)淨額26.3%22.3%26.1%26.3%26.7%
推銷費用8.7%7.0%8.8%9.4%10.2%
管理費用6.4%5.5%6.6%6.4%6.7%
預期信用減損損失(利益)-0.0%0.1%0.2%0.0%0.1%
營業費用合計15.1%12.6%15.6%15.8%16.9%
營業利益(損失)11.2%9.7%10.4%10.5%9.8%
利息收入0.2%0.2%0.3%0.2%0.3%
其他收入0.1%0.1%0.2%0.3%0.2%
其他利益及損失淨額0.3%-0.4%0.2%0.2%0.6%
財務成本淨額0.4%0.3%0.3%0.3%0.4%
採用權益法認列之關聯企業及合資損益之份額淨額0.2%0.2%0.3%0.3%0.3%
營業外收入及支出合計0.5%-0.1%0.7%0.7%0.9%
稅前淨利(淨損)11.7%9.6%11.1%11.2%10.7%
所得稅費用(利益)合計2.2%1.8%2.2%2.3%2.0%
繼續營業單位本期淨利(淨損)9.5%7.8%8.9%8.8%8.6%
本期淨利(淨損)9.5%7.8%8.9%8.8%8.6%
確定福利計畫之再衡量數-0.3%0.2%-0.0%0.0%0.0%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益-0.0%-0.0%-0.8%-0.1%
不重分類至損益之項目:-0.3%0.2%-0.0%-0.8%-0.1%
國外營運機構財務報表換算之兌換差額-0.0%0.0%-0.0%0.1%-0.1%
後續可能重分類至損益之項目:-0.0%0.0%-0.0%0.1%-0.1%
其他綜合損益(淨額)-0.4%0.2%-0.1%-0.7%-0.2%
本期綜合損益總額9.1%8.0%8.9%8.1%8.4%
母公司業主(淨利∕損)9.5%7.8%8.9%8.8%8.6%
母公司業主(綜合損益)9.1%8.0%8.9%8.1%8.4%
基本每股盈餘0.2%0.2%0.2%0.2%0.2%
稀釋每股盈餘0.2%0.2%0.2%0.2%0.2%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。